Skip to content
BIOPHOTONIXBioPhotonix
← All articles

Weekly insight · 9 November 2026 · 4 min read

Diabetic eye screening every 2 years: the evidence, and who waits

By Adail Islam, optometrist and orthoptist, Founder and Director

2 clear screens, then 2 years: the risk, and what a 2-year cycle delays

Four Nations study: 7 UK programmes, graded 2005 to 2012

354,549
people with diabetes in the analysis
0.3% to 1.3%
of people with 2 clear screens: referable in 2 years
under 0.3%
of people with 2 clear screens: proliferative in 2 years

% of sight-threatening diagnoses that come a screen later

  • 2-yearly, North East London39%
  • Points score, North East London25%
  • 2-yearly, South East London (test)34%
  • Points score, South East London (test)22%
Four Nations: % of people with no retinopathy at 2 screens. London: % of sight-threatening diagnoses among 105,083 (North East) and 79,296 (South East, where the score was tested) people with 2 clear screens, 2012 to 2023. Source: Leese et al., Diabetes Care 2015; Pitt et al., Diabetologia 2025

In brief

  • Since October 2023, England has been moving people whose last 2 routine screens found no retinopathy to screening every 2 years, in stages. Scotland, Wales and Northern Ireland changed first.
  • The evidence was retrospective: of 354,549 people in 7 UK programmes, 0.3% to 1.3% of those with 2 clear screens progressed to referable retinopathy within 2 years.
  • Replaying North East London's records on a 2-year cycle put 39% of sight-threatening diagnoses a screen later, with more building up in groups already at higher risk.
  • The College asks optometrists to check when the last screen was, keep usual sight-test recall with judgement for higher-risk groups, and report what they find.

In North East London's records, a 2-year gap between diabetic eye screens would have pushed 39% of sight-threatening diagnoses in people with 2 clear screens back a screen, a simulation published in Diabetologia found. Since October 2023, England has been moving people whose last 2 routine screens found no retinopathy onto diabetic eye screening every 2 years instead of every year.

It follows a 2016 recommendation from the UK National Screening Committee, and Scotland, Wales and Northern Ireland made the change before England. NHS England tells people on the longer interval to see their optometrist straight away if their sight changes.

Who is on diabetic eye screening every 2 years

In England it takes no retinopathy and no maculopathy in either eye (R0M0) at the last 2 routine screens. One microaneurysm makes a screen R1, and R1 alone means yearly screening again, while maculopathy (M1) means OCT surveillance. Pregnant women are screened more often. A review in Eye Open adds that people with type 1 diabetes starting a hybrid closed loop system are exempt, those starting an insulin pump stay yearly for a year, and the change has been staggered since a 2024 software upgrade.

What the evidence behind the change showed

The UK National Screening Committee relied on the Four Nations study, published in Diabetes Care. It pooled 2005 to 2012 grading results for 354,549 people in 7 programmes: the national ones of Scotland, Wales and Northern Ireland, and 4 in England. Of people with no retinopathy at 2 screens at least 12 months apart, 0.3% to 1.3% progressed to referable retinopathy within 2 years, and fewer than 0.3% to proliferative disease. With background retinopathy in both eyes at both screens, the figures were 13% to 29% and up to 4%.

It was retrospective, and its authors wrote that it could not directly show the effect of changing the interval. The nearest test is Liverpool's ISDR trial, which randomised 4,534 people to yearly screening or to 6, 12 or 24 months set by a risk calculator using clinical data. Attendance at first follow-up was equivalent (83.6% against 84.7%), sight-threatening retinopathy was found in 1.4% against 1.7% over 2 years, and the individualised arm needed 43.2% fewer appointments.

What London's records added

Pitt and colleagues took North East London's records from 2012 to 2023, when everyone was still invited yearly, and found 105,083 people with 2 clear screens. Over a mean of 5 years, 3,694 developed sight-threatening retinopathy, meaning a screening grade of R2, R3 or M1. The paper does not say how many were proliferative. Replaying the records on a 2-year cycle cut appointments by 54%, but 1,444 of those diagnoses, 39%, would have come a screen later.

The risk was uneven before the interval changed. Against the lowest-risk group, white people aged 41 or over with diabetes for under 10 years, almost every group was significantly more likely to have a sight-threatening diagnosis at an appointment: South Asian people 1.61 to 3.12 times, Black people 2.27 to 4.10, highest at 40 or under. The ratios were much the same with yearly screening, but a 2-year gap lets more build up: for Black people, the chance at each appointment rose from 0.8% to 2.4%, against 1% for the lowest-risk group. A points score using age, diabetes duration and ethnicity cut delayed diagnoses to 25% while saving 43% of appointments, and from 34% to 22% when tested on South East London's records.

Why it matters in practice

The College of Optometrists' guidance covers the year between screens:

  • Ask whether the patient is in a screening programme and when they last attended, and say if you think it is overdue.
  • Keep sight-test recall as for someone without diabetes, whatever their screening interval, but use your judgement for younger people and people of Black and Asian ethnicities.
  • Dilating solely to look for retinopathy is not needed where a screening programme is in place.
  • Report relevant findings to whoever is responsible for the patient's care.

Beyond the guidance, record the result of the last screen as well as its date. Background retinopathy in someone on the 2-year cycle is a relevant finding to report, though a report does not by itself change their screening interval. Younger patients may matter twice: in London, people aged 40 or under were particularly at risk beyond 3 years, and a September review of 14 UK studies from 2006 to 2021 found younger age, in bands such as 12 to 39, and deprivation the most consistent markers of missed or late screening.

The caveats

  • The Four Nations study used 2005 to 2012 data, and its authors said the spread between programmes may partly reflect grading.
  • London's 39% is a simulation on yearly-screening records, so it cannot show how people respond to fewer invitations.
  • ISDR tested a clinical-data calculator, not England's rule, in one programme whose participants were 94.6% white, over 2 years.
  • The points score needs recorded ethnicity, which some programmes hold incompletely.
  • London's funders were Wellcome, the Health Foundation, the NHS Transformation Directorate and the NIHR. Its authors also research automated grading, covered on our news page.

Questions this raises

How often should you have diabetic eye screening?

Across the UK, people with diabetes aged 12 and over are offered screening, and all four nations now screen people at low risk every 2 years under their own programme rules. In England, low risk means no retinopathy in either eye at the last 2 routine screens. There, background retinopathy without maculopathy means yearly screening, maculopathy means OCT surveillance, and more advanced changes mean closer monitoring or a hospital referral. Pregnant women are screened more often.

Is diabetic eye screening every 2 years safe?

For the group it covers, the average risk is low. In the Four Nations study of 354,549 people, 0.3% to 1.3% of those with 2 clear screens progressed to referable retinopathy within 2 years. Liverpool's ISDR trial tested a risk calculator using clinical data, not England's rule, in a mostly white population: attendance was equivalent, and detection non-inferior within its 1.5-point margin (1.4% against 1.7%). A simulation on North East London's records found 39% of sight-threatening diagnoses after 2 clear screens would have come a screen later.

How often should people with diabetes have an eye test?

The College of Optometrists says that for a patient in an NHS diabetic eye screening programme, sight-test recall should be the same as for someone without diabetes, whether screening is every 6, 12 or 24 months. It asks optometrists to use their judgement for younger people and people of Black and Asian ethnicities, who are affected by sight-threatening retinopathy more. An examination or photographs at a practice are not an alternative to the NHS screening programme, and the College asks optometrists to say so.

Why did diabetic eye screening change to every 2 years?

The UK National Screening Committee recommended it in 2016 for people at low risk of sight loss, after a large study found that few people with 2 clear screens progressed to referable retinopathy within 2 years. NHS England says the change frees appointments for people at higher risk and spares low-risk people a yearly visit. Scotland, Wales and Northern Ireland made the change before England, which followed from October 2023.

The weekly insight summarises published research and news for eye-care professionals. It is not clinical advice, and BioPhotonix had no part in the work described unless the article says so.

Interested in Revolux?

Whether you run a practice or are looking at BioPhotonix as an investor, we would like to hear from you.

Get in touch